Global Vitamin D Therapy Market
Vitamin D is defined as the fat soluble vitamin that is responsible for maintaining healthy bones and teeth. Although our body cannot produce vitamin D, it is obtained mainly by skin production during sun exposure. Vitamin D deficiency causes sore bones and weakened muscles. Vitamin D therapy is provided to treat various conditions including rickets, muscle weakness, osteoporosis, skin conditions, and others.
The increase in the target patient population is the key driver that is expected to drive the growth of the global vitamin D therapy market during the forecast period. Additionally, increasing awareness of vitamin D deficiency, increasing patient compliance with oral medications, increasing prevalence of hypovitaminosis D, sedentary lifestyles, aging population, and lack of sun exposure are some of the prominent factors that global vitamin D therapy is expected to drive market growth.
Get a free sample request @ https://qualiketresearch.com/request-sample/Vitamin-D-Therapy-Market/request-sample
In addition, strategic acquisitions and mergers between companies contribute to the growth of the vitamin D therapy market.For example, in 2018, GSK completed the purchase of Novartis' 36.5% stake in the Consumer Healthcare Joint Venture and GSK had entered in collaboration with Pfizer to form a consumer healthcare joint venture that would provide a range of vitamin and mineral products. supplements, therapeutic oral health, skin, respiratory, analgesic and digestive health, among others.
Furthermore, the increased use of vitamin D in the treatment of diseases is expected to provide a significant opportunity to the market for vitamin D therapy. For example, a research article published in "Clinical Breast Cancer," a journal published by Elsevier found that taking vitamin D supplements with chemotherapy can improve disease-free survival in women with HER2 + breast cancer. The study reveals that patients who took vitamin D supplements during treatment have better survival compared to patients who did not take vitamin D supplements. This research is expected to drive growth in the vitamin D therapy market in the future. next.
Increasing cases of a medical condition associated with excessive vitamin D consumption is expected to restrict the growth of the vitamin D therapy market. A high level of vitamin D in the body can cause vitamin D toxicity commonly called hypervitaminosis D Although rare, the serious condition can result in a build-up of excess calcium in the blood, which is called hypercalcemia. Therefore, excessive consumption of vitamin D can lead to serious medical conditions; This factor is expected to hamper the growth of the vitamin D therapy market.
Ask about this report @ https://qualiketresearch.com/request-sample/Vitamin-D-Therapy-Market/inquire-before-buying
Regional analysis
The global vitamin D therapy market is segmented into five regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa.
Asia Pacific is expected to expand to the highest CAGR during the forecast period, due to awareness of vitamin D deficiency, as well as government policies and programs supporting the implementation of vitamin deficiency treatment plans. D, sedentary lifestyles, increasing incidence of vitamin D deficiency, decreased sun exposure, atypical diets, and increased levels of malnutrition.
Additionally, North America is projected to dominate the vitamin D therapy market during this forecast schedule. Due to the presence of leading US-based players, focus on research activities to develop more patient-friendly products with greater efficiency along with government support and increased healthcare spending that contributes to your Outstanding share of market revenue in overall market growth.
Key player analysis
Several key players are listed in this report, such as Abbott Laboratories, Novartis International AG, Torrent Pharmaceuticals Ltd., Merck & Co., Inc., Sanofi, Pfizer, Inc., Cadila Healthcare Ltd., Sun Pharmaceutical Industries Ltd, Biotics Research Corporation , Alkem Laboratories Ltd, etc. Abbott Laboratories has a global distribution network and a good brand reputation among end users. The company's strong presence, as well as extensive distribution channels around the world, have helped it maintain its leading position in the market. The company focuses on mergers and acquisitions, with strategic alliances such as technology, licenses, to obtain an advantage over competitors.
Market taxonomy
By way of administration
By application
- Rickets
- Muscular weakness
- Osteoporosis
- Skin diseases
- Others
By region
- North America
- Latin America
- Europe
- Pacific Asia
- Middle East and Africa
Browse the full report @ https://qualiketresearch.com/reports-details/Vitamin-D-Therapy-Market
About us
QualiKet Research is a leading market research and competitive intelligence partner that helps leaders around the world develop a solid strategy and stay ahead of evolution by providing actionable insights on the market, competition and customer scenario. constantly changing. QualiKet Research is dedicated to enhancing the ability for faster decision making by providing timely and scalable intelligence. We use different intelligence tools to generate evidence that shows the threats and opportunities that help our clients outperform the competition.
